PATHS helps students from underrepresented backgrounds realize med school dreams
Nelson Perez Catalan discovered he was interested in pursuing science while working at a student job at the University of Oregon cleaning glass in the labs. He found himself drawn to research around the brain, and thought about pursuing an MD/PhD, but there was no medical school at his university and as a transplant from Chile, he says much of the U.S. college process was mystifying to him. Then he learned about PATHS, or Program to Advance Training in Health and Sciences at Yale School of Medicine.
CELLO Study to Explore Early Treatment of Multiple Sclerosis
Yale University announced today the initiation of a multicenter study aimed at treating early stage multiple sclerosis (MS). Supported by and in collaboration with Genentech, a member of the Roche Group, the study, known as “CELLO,” will investigate whether short-term treatment with ocrelizumab in patients with MRI lesions consistent with early MS without clinical disease—known as radiologic isolated syndrome—prevents the onset of symptoms.
A new treatment may halt cluster headaches. But some say psychedelic drugs are the real answer.
There are few successful treatment options for cluster headache, a rare, misunderstood, and intensely painful neurologic condition. However, new research suggests that psychedelic drugs may provide relief.Source: The Washington Post
Chronic Headache Disorders & Toxic Exposure: A Policy Panel Discussion
Right now, over 230,000 veterans have joined VA’s Airborne Hazards and Open Burn Pit Registry which documents self-reported health impacts. While much is still unknown, veterans exposed to burn pits report unexplained chronic illnesses, cancers, and respiratory conditions. For many veterans, that means living with debilitating headaches and chronic migraines. Currently, over one million veterans seeking care at VA are diagnosed with a headache disorder and 22 percent of veterans deployed with duties involving burn pits report functional limitations due to migraines. We have a responsibility to care for all those who have borne the battle-- we cannot leave these veterans behind. I’ve made addressing toxic exposure a top priority this Congress, and I am committed to moving forward comprehensive legislation to ensure all of our veterans exposed to toxic substances during their service can access the care and benefits they’ve earned—regardless of where or when they served.Source: Headache & Migraine Policy Forum
National Multiple Sclerosis Society Postdoctoral Fellowship Awarded to Dr. Soumya Yandamuri
Postdoctoral Fellow Dr. Soumya Yandamuri, MSE, PhD has been awarded the National Multiple Sclerosis Society Postdoctoral Fellowship. The grant, “Isolation and characterization of myelin oligodendrocyte glycoprotein monoclonal antibodies,” funds three years and will begin in July 2021.
Wellness Wednesday: Program helps veterans who suffer from chronic headaches
Dr. Jason Sico, the national director for the Veterans Health Administration Headache Center for Excellence, meets with his patients virtually nowadays. “I’ve been doing telehealth for 10 years and it’s been ramped up in earnest during the pandemic,” he said. The program he runs aims to better understand how veterans are suffering. “Trying to get a sense of how many veterans have headaches, what type of headache disorders do they have, what kind of treatments are they getting, do they live in rural areas, urban areas,” Sico added. They then put the data into action, to meet the needs that are out there. “In order to improve something, you have to understand what the baseline is,” he said. “We know traumatic brain injury, the signature injury, can lead to headache. It’s become increasingly important for Congress, as well as the Veterans Health Administration, to understand how many veterans have headaches and how we can do our best to help them.”Source: EyeWitness News 3
Dr. Guido Falcone Selected for Michael S. Pessin Stroke Leadership Prize
The American Academy of Neurology has awarded Assistant Professor of Neurology Dr. Guido Falcone, MD, ScD, MPH with the 2021 Michael S. Pessin Stroke Leadership Prize in recognition of his outstanding achievements in stroke research.
Yale Neurologists Identify Consistent Neuroinflammatory Response in ICH Patients
According to a recent study published in "Science Immunology," A team of researchers from Yale and MIT partnernered with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients suffering from intracerebral hemorrhage.
Dr. David Hafler Elected to the Association of American Physicians
David Hafler, MD, FANA, William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology; Chair, Department of Neurology; Neurologist-in-Chief, Yale New Haven Hospital has been elected to the Association of American Physicians (AAP).
After a COVID Diagnosis, When Should I Get Vaccinated? Neurovirologists On This and Other Uncharted Scenarios on the COVID Vaccine
With more and more neurologists now having been vaccinated, several scenarios have arisen for which there is no clear guidance and for which policies have varied across institutions. We asked experts in neurovirology and neuroimmunology to consider those situations based on real-life questions from our readers.Source: NeurologyToday
$11.12M gift supporting hemorrhagic stroke treatment launches innovative research network
Research teams from Massachusetts General Hospital, Yale University and University of California, San Francisco form the American Heart Association’s newest stroke scientific research network funded by Henrietta B. and Frederick H. Bugher FoundationSource: American Heart Association